Back to Search Start Over

Patient with adrenal insufficiency due to a de novo mutation in the NR0B1 gene

Authors :
Daniel Bravo Nieto
Alba S. García Fernández
Noelia Díaz Troyano
Marina Giralt Arnaiz
Andrea Arias García
Paula Fernández Álvarez
Ariadna Campos Martorell
Roser Ferrer Costa
María Clemente León
Source :
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio.
Publication Year :
2023
Publisher :
Walter de Gruyter GmbH, 2023.

Abstract

Objectives Congenital X-linked adrenal hypoplasia is a rare disease with a known genetic basis characterized by adrenal insufficiency, hypogonadotropic hypogonadism, and a wide variety of clinical manifestations. Case presentation We present the case of a 26-day old male newborn with symptoms consistent with adrenal insufficiency, hyponatremia, and hyperkalemia. Following NaCl and fludrocortisone supplementation, the patient remained clinically stable. 17-OH-progesterone testing excluded congenital adrenal hyperplasia. The rest of hormones were within normal limits, except for adrenocorticotropic hormone (ACTH), which was significantly elevated, and aldosterone, which was below the reference value. Further testing included very long chain fatty acids to exclude adrenoleukodystrophy, the CYP11B2 gene (aldosterone synthase), and an MRI to screen for other morphological abnormalities. All tests yielded normal results. Finally, after cortisol deficiency was detected, expanded genetic testing revealed a mutation in the NR0B1 gene, which led to a diagnosis of congenital adrenal hypoplasia. Conclusions Diagnosis of congenital adrenal hypoplasia is challenging due to the heterogeneity of both clinical manifestations and laboratory abnormalities. As a result, diagnosis requires close monitoring and genetic testing.

Details

ISSN :
2628491X
Database :
OpenAIRE
Journal :
Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
Accession number :
edsair.doi...........1250ce88e19513a2e5334c29455714f6
Full Text :
https://doi.org/10.1515/almed-2023-0018